Winstanley Enterprises, BioMed Realty Trust, The Medicines Company, The Hampshire Companies, RedPath Integrated Pathology, Omnicare Clinical Research | GenomeWeb

Report: Winstanley Buys 25 Science Park in New Haven, Conn., for $14.5M from BMR
 
Winstanley Enterprises of Concord, Mass., has added to its life sciences portfolio in New Haven, Conn., by acquiring a ground lease for the 270,000-square-foot 25 Science Park (150 Munson St.) from BioMed Realty Trust for $14.5 million, according to a third-quarter office market report by the commercial real estate brokerage Colliers Dow & Condon.
 

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

The Wall Street Journal reports that National Institutes of Health Director Francis Collins' response to contamination concerns at the agency might have delayed care.

The final revision of the Common Rule doesn't include the proposed change requiring consent for leftover biospecimens.

The first Reproducibility Project: Cancer Biology papers show mixed results.

In Nature this week: mobile phone-based targeted DNA sequencing, and more.